Primer: SK Biopharmaceuticals (326030 KS) - Aug 2026
SK Biopharmaceuticals is successfully transitioning into a profitable, commercial-stage company, driven by the robust sales growth of its...
114 Views
Lee Jae-Myung Becomes the New South Korean President - Four Investment Themes That Could Outperform
In this insight, we discuss four investment themes (related to Lee Jae-Myung becoming the new South Korean President) that could outperform the...
1.2k Views
HK Inno.N (195940 KS): Modest Show In 1Q26; All Eyes on Maiden US Approval; Strengthening Pipeline
HK inno reports 1Q26 result, with key parameters showing improvement compared to year-ago period. The company is expected to maintain momentum,...
426 Views
2026 High Conviction Idea: SK Inc
SK Inc (034730 KS) just announced that it will cancel about 20% of its outstanding shares, representing 4.8 trillion won ($3.3 billion). This is...
1k Views
SK Inc: Selling 1.25 Trillion Won Worth of SK Biopharm Through a PRS Contract
SK Inc (034730 KS) announced that it plans to sell about 1.25 trillion won worth of its stake (13.94%) in SK Biopharmaceuticals (326030 KS) through...
404 Views